Skip Header

 

11 results for uniprot:Q86XA6Drop in citationmapping

Customize display Download...

Page 1 of 1

Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId.

Hansske B., Thiel C., Lubke T., Hasilik M., Honing S., Peters V., Heidemann P.H., Hoffmann G.F., Berger E.G., von Figura K. et al.

J. Clin. Invest. 109:725-733(2002) GeneRIF 2683 · Mapped (5)
deficiency causes a new congenital disorder of glycosylation (CDG) designated type IId (CDG-IId) a severe neurologic disease characterized by hydrocephalus myopathy and blood-clotting defects GeneRIF 2683

Elevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator.

Zhu X., Jiang J., Shen H., Wang H., Zong H., Li Z., Yang Y., Niu Z., Liu W., Chen X. et al.

J. Biol. Chem. 280:12503-12516(2005) GeneRIF 2683 · Mapped (9)
E1AF has an essential role in the activation of the human GalT I gene in highly metastatic lung cancer cells GeneRIF 2683

Tumor necrosis factor-alpha up-regulates the expression of beta1,4-galactosyltransferase I in primary human endothelial cells by mRNA stabilization.

Garcia-Vallejo J.J., van Dijk W., van Die I., Gringhuis S.I.

J. Biol. Chem. 280:12676-12682(2005) GeneRIF 2683 · Mapped (11)
TNFalpha modulates the glycosylation of endothelial cells by a mechanism that directly enhances the stability of beta4GalT-1 mRNA transcripts GeneRIF 2683

Oligosaccharide preferences of beta1,4-galactosyltransferase-I: crystal structures of Met340His mutant of human beta1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety.

Ramasamy V., Ramakrishnan B., Boeggeman E., Ratner D.M., Seeberger P.H., Qasba P.K.

J. Mol. Biol. 353:53-67(2005) GeneRIF 2683 · Mapped (5)
beta4Gal-T1 interacts preferentially with the 1 2-1 6-arm trisaccharide rather than with the 1 2-1 3-arm or 1 4-1 3-arm of a bi- or tri-antennary oligosaccharide chain of N-glycan GeneRIF 2683

An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes.

Bakker H., Rouwendal G.J., Karnoup A.S., Florack D.E., Stoopen G.M., Helsper J.P., van Ree R., van Die I., Bosch D.

Proc. Natl. Acad. Sci. U.S.A. 103:7577-7582(2006) GeneRIF 2683 · Mapped (6)
Data show that expression of a hybrid enzyme of Arabidopsis thaliana xylosyltransferase and human beta-1 4-galactosyltransferase I in tobacco causes a reduction of N-glycans with potentially immunogenic core-bound xylose and fucose residues. GeneRIF 2683

Cell surface beta 1, 4-galactosyltransferase 1 promotes apoptosis by inhibiting epidermal growth factor receptor pathway.

Li Z., Zong H., Kong X., Zhang S., Wang H., Sun Q., Gu J.

Mol. Cell. Biochem. 291:69-76(2006) GeneRIF 2683 · Mapped (20)
These results demonstrated that cell surface beta1 4GT1 may negatively regulate cell survival possibly through inhibiting and modulating EGFR signaling pathway. GeneRIF 2683

Transition of galactosyltransferase 1 from trans-Golgi cisterna to the trans-Golgi network is signal mediated.

Schaub B.E., Berger B., Berger E.G., Rohrer J.

Mol. Biol. Cell 17:5153-5162(2006) GeneRIF 2683 · Mapped (5)
Cycling between the trans-Golgi cisterna and the trans-Golgi network of galT is signal mediated. GeneRIF 2683

Identification of beta-1,4-galactosyltransferase I as a target gene of HBx-induced cell cycle progression of hepatoma cell.

Wei Y., Liu D., Zhou F., Ge Y., Xu J., Yun X., Gu J., Jiang J.

J. Hepatol. 49:1029-1037(2008) GeneRIF 2683 · Mapped (5)
hepatitis B-induced GalT I expression might contribute to hepatitis B-mediated hepatocellular carcinoma development and progression GeneRIF 2683

Deoxygenated disaccharide analogs as specific inhibitors of beta1-4-galactosyltransferase 1 and selectin-mediated tumor metastasis.

Brown J.R., Yang F., Sinha A., Ramakrishnan B., Tor Y., Qasba P.K., Esko J.D.

J. Biol. Chem. 284:4952-4959(2009) GeneRIF 2683 · Mapped (5)
Deoxygenated disaccharide analogs as specific inhibitors of beta1-4-galactosyltransferase 1 and selectin-mediated tumor metastasis. GeneRIF 2683

Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease.

Chapuis J., Hot D., Hansmannel F., Kerdraon O., Ferreira S., Hubans C., Maurage C.A., Huot L., Bensemain F., Laumet G. et al.

Mol. Psychiatry 14:1004-1016(2009) GeneRIF 2683 · Mapped (315)
Observational study of gene-disease association. (HuGE Navigator) GeneRIF 2683

Association of beta-1,3-N-acetylglucosaminyltransferase 1 and beta-1,4-galactosyltransferase 1, trans-Golgi enzymes involved in coupled poly-N-acetyllactosamine synthesis.

Lee P.L., Kohler J.J., Pfeffer S.R.

Glycobiology 19:655-664(2009) GeneRIF 2683 · Mapped (9)
These results demonstrate that B3GNT1 and B4GALT1 physically associate in vitro and in cultured cells providing insight into possible mechanisms for regulation of polyLacNAc production. GeneRIF 2683

Page 1 of 1